Breast cancer (BC) ranks first among all malignant neoplasms in the female population. The World Health Organization’s International Agency for Research on Cancer (IARC) predicts that by 2050, more than 35 million new cases of cancer will be recorded (77% more than in 2022), and the number of fatalities will double to over 18 millions. In the structure of malignant neoplasms, polyneoplasia accounts for an average of 2.47%, and according to many authors, its share has been increasing in recent decades. Among women, the reproductive system is the most vulnerable to primary multiple malignant tumors. It shoud be mentioned that the most common combinations are hormone-dependent formations (breast cancer (BC), uterine cancer (UC), and ovarian cancer (OC)) with colorectal cancer (CRC) and gastric cancer (GC). Diseases of civilization, which have engulfed the planet over the past 15 years, have had a significant impact on this phenomenon. Objective of the study. To analyze cases of metachronous neoplasia in patients with breast cancer, including age structure, the timing of the second neoplasm occurrence, distribution by stage, and molecular subtype of BC. Materials and methods. A retrospective study of 73 patients with breast cancer who received comprehensive treatment at the KNP "Prykarpattia Clinical Oncology Center of the Ivano-Frankivsk Regional Council" from 2019 to 2023 was conducted. Only those patients who faced primary multiple malignant tumors were considered. Results. From 2019 to 2023, the structure of patients with primary multiple BC was dominated by those with metachronous EC, OC, CRC, or GC (44%). In patients with breast cancer, metachronous endometrial or colorectal cancer mostly occurred after 10 years (33.33% and 52.17%, respectively). Gastric cancer was most often diagnosed within one year (40%), and ovarian cancer within 5 years (50%). Women aged 50 to 59 years (working-age population) were usually affected by primary multiple breast cancer. Metachronous EC, OC, and CRC mostly occurred in patients with primary diagnosed stage IIA-IIB BC (54.17%, 58.33%, and 50%, respectively). Statistically significant data on metachronous GC have not yet been obtained. Endometrial, ovarian, and colorectal cancers are most often associated with hormone-dependent subtypes of breast cancer: EC and OC with luminal B (38.89% and 57.14%, respectively), and CRC with luminal A (44.45%). GC is equally associated with luminal B and Her2/neu-positive subtypes (50% each). Conclusions. Metachronous tumors of the uterus, ovary, colon, and stomach were mostly diagnosed in women aged 59-59, who belong to the working population. Based on our analysis we can consider that uterine and colon cancer more often occurred after 10 years, gastric cancer within one year and ovarian cancer within 5 years. The obtained results demonstrate the necessity for further study of the relationship between breast cancer and metachronous cancers of the uterus, ovary, colon, and stomach. More attention should be paid to genetic factors, the impact of hyperestrogenism, diabetes mellitus, obesity, and other concomitant nosologies. The acquired knowledge should be directed towards improving screening programs and early diagnosis for both breast cancer and polyneoplasia. Considering all key factors, an attempt should be made to develop an algorithm for calculating the risk of metachronous tumors in patients with primary-diagnosed breast cancer. Рак грудної залози (РГЗ) посідає перше місце серед усіх злоякісних новоутворень жіночого населення. Міжнародне агентство ВООЗ із дослідження раку (IARC) прогнозує до 2050 року значне збільшення захворюваності на рак і подвоєння летальних випадків. У структурах злоякісних новоутворень полінеоплазії займають у середньому 2,47%, і їхня частка продовжує зростати. Серед жінок найбільш уразливою до первинно-множинних злоякісних пухлин є репродуктивна система. Найчастіше спостерігаємо поєднання гормонально-залежних утворень (раку грудної залози (РГЗ), тіла матки (РТМ) і яйників (РЯ)) із раком товстої кишки (РТК) та шлунка (РШ)). Вагомий вплив на це явище мають хвороби цивілізації. Мета дослідження. Проаналізувати метахронні неоплазії в пацієнток на рак грудної залози. Матеріали і методи. Ретроспективно досліджено 73 пацієнтки з метахронними полінеоплазіями, які лікувалися в КНП “ПКОЦ ІФ ОР” із 2019 по 2023. Результати. У структурі пацієнток на первинно-множинний РГЗ переважали працездатні жінки (50-59 років) з метахронними РТМ, РЯ, РТК чи РШ (44%). Рак тіла матки й товстої кишки здебільшого діагностували через 10 років (33,33% і 52,17% відповідно), рак шлунка – упродовж року (40%), а рак яйника – за 5 років (50%). Згадані метахронні пухлини здебільшого виникали в пацієнток на первинно-діагностований РГЗ ІІА-ІІВ стадії. РТМ і РЯ найчастіше асоціюються з люмінальним В типом РГЗ (38,89% і 57,14%...